HUP0500097A2 - Nyújtott/szabályozott hatóanyag-leadású szilárd készítmény, mint kisebb dózisveszteséget mutató új hatóanyag-adagoló rendszer - Google Patents

Nyújtott/szabályozott hatóanyag-leadású szilárd készítmény, mint kisebb dózisveszteséget mutató új hatóanyag-adagoló rendszer

Info

Publication number
HUP0500097A2
HUP0500097A2 HU0500097A HUP0500097A HUP0500097A2 HU P0500097 A2 HUP0500097 A2 HU P0500097A2 HU 0500097 A HU0500097 A HU 0500097A HU P0500097 A HUP0500097 A HU P0500097A HU P0500097 A2 HUP0500097 A2 HU P0500097A2
Authority
HU
Hungary
Prior art keywords
sustained
release solid
delivery system
drug delivery
controlled release
Prior art date
Application number
HU0500097A
Other languages
English (en)
Inventor
M. Zahirul I. Khan
Aleksandra Krajacic
Zdravka Knezevic
Snjezana Vodopija-Mandic
Original Assignee
Pliva Istrazivanje I Razvoj D.O.O.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Istrazivanje I Razvoj D.O.O. filed Critical Pliva Istrazivanje I Razvoj D.O.O.
Publication of HUP0500097A2 publication Critical patent/HUP0500097A2/hu
Publication of HUP0500097A3 publication Critical patent/HUP0500097A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A találmány tárgya nyújtott hatóanyag-leadású szilárd dózisforma,amely tartalmaz a) egy granulátumot, amely egy gyógyszer-hatóanyagotés egy farmakológiailag alkalmazható, vízben oldhatatlan,vízpermeábilis polimer anyag keverékét tartalmazza, és b) egygyógyszer-hatóanyagot és legalább 2 tömeg% vízben oldhatatlan,vízimpermeábilis hidrofób anyagot. A találmány kiterjed a fentigyógyszerkészítmény előállítására és alkalmazására. Ó
HU0500097A 2002-02-11 2002-03-27 Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping HUP0500097A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HR20020124A HRP20020124A2 (en) 2002-02-11 2002-02-11 Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping
PCT/HR2002/000018 WO2003074033A1 (en) 2002-02-11 2002-03-27 Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping

Publications (2)

Publication Number Publication Date
HUP0500097A2 true HUP0500097A2 (hu) 2005-07-28
HUP0500097A3 HUP0500097A3 (en) 2008-04-28

Family

ID=27772919

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0500097A HUP0500097A3 (en) 2002-02-11 2002-03-27 Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping

Country Status (17)

Country Link
US (1) US20050118266A1 (hu)
EP (1) EP1474112A1 (hu)
JP (1) JP2006507216A (hu)
AU (1) AU2004205184A1 (hu)
BG (1) BG108870A (hu)
CA (1) CA2476050A1 (hu)
CZ (1) CZ2004931A3 (hu)
EE (1) EE200400110A (hu)
HR (1) HRP20020124A2 (hu)
HU (1) HUP0500097A3 (hu)
IS (1) IS7386A (hu)
NO (1) NO20043818L (hu)
PL (1) PL371787A1 (hu)
RS (1) RS70704A (hu)
RU (1) RU2004127237A (hu)
SK (1) SK3302004A3 (hu)
WO (1) WO2003074033A1 (hu)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2244324B1 (es) 2004-03-25 2006-11-16 Ferrer Internacional, S.A. Composiciones diureticas de liberacion prolongada.
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
AU2005320547B2 (en) * 2004-12-27 2009-02-05 Eisai R & D Management Co., Ltd. Method for stabilizing anti-dementia drug
DE102006051020A1 (de) * 2006-10-26 2008-04-30 Evonik Röhm Gmbh Verwendung von (Meth)acrylat-Copolymeren in Retard-Arzneiformen zur Verringerung des Einflusses von Ethanol auf die Wirkstofffreisetzung
NO2197534T3 (hu) * 2007-09-25 2018-08-04
US8926490B2 (en) * 2008-09-24 2015-01-06 Neosync, Inc. Systems and methods for depression treatment using neuro-EEG synchronization therapy
WO2011017466A1 (en) 2009-08-06 2011-02-10 Neosync, Inc. Systems and methods for modulating the electrical activity of a brain using neuro-eeg synchronization therapy
WO2011036114A1 (en) * 2009-09-25 2011-03-31 Novartis Ag Oral pharmaceutical composition comprising diclofenac
EP2498857B1 (en) 2009-11-12 2020-04-29 Neosync, INC. Systems and methods for neuro-eeg synchronization
WO2011102504A1 (ja) 2010-02-22 2011-08-25 第一三共株式会社 経口用徐放性固形製剤
TW201200165A (en) 2010-02-22 2012-01-01 Daiichi Sankyo Co Ltd Oral solid extended release dosage form
MX339408B (es) * 2010-03-09 2016-05-24 Alkermes Pharma Ireland Ltd Composiciones farmaceuticas entericas resistentes al alcohol.
CN104768552A (zh) 2012-09-03 2015-07-08 第一三共株式会社 含有盐酸氢吗啡酮的口服持续释放药物组合物
WO2014060857A1 (en) * 2012-10-19 2014-04-24 Wockhardt Limited Pharmaceutical compositions of diclofenac or salts thereof
US10588576B2 (en) 2014-08-15 2020-03-17 Neosync, Inc. Methods and device for determining a valid intrinsic frequency
JP1602547S (hu) 2017-01-17 2018-04-23

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN156886B (hu) * 1981-08-22 1985-11-30 Council Scient Ind Res
NL8500724A (nl) * 1985-03-13 1986-10-01 Univ Groningen Inrichtingen voor geregelde afgifte van werkzame stoffen, alsmede werkwijze ter vervaardiging daarvan.
DE3822095A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Neue arzneimittelformulierung sowie verfahren zu deren herstellung
AU645003B2 (en) * 1988-11-08 1994-01-06 Takeda Chemical Industries Ltd. Sustained release preparations
US4948581A (en) * 1989-02-17 1990-08-14 Dojin Iyaku-Kako Co., Ltd. Long acting diclofenac sodium preparation
JP2572673B2 (ja) * 1990-07-25 1997-01-16 エスエス製薬株式会社 徐放性錠剤
ES2107685T3 (es) * 1992-10-16 1997-12-01 Glaxo Group Ltd Composiciones de ranitidina que enmascaran su sabor.
US6183778B1 (en) * 1993-09-21 2001-02-06 Jagotec Ag Pharmaceutical tablet capable of liberating one or more drugs at different release rates
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
DE19524753A1 (de) * 1995-07-07 1997-01-23 Lohmann Therapie Syst Lts Schichttablette zur kontrollierten Freisetzung von Wirkstoffen
DE69713948D1 (de) * 1996-04-23 2002-08-22 Janssen Pharmaceutica Nv Rasch-freisetzende pH-unabhängige feste Dosisformen enthaltend Cisaprid
CN1165291C (zh) * 1996-05-20 2004-09-08 詹森药业有限公司 具有改进的生物利用度的抗真菌组合物
US6294199B1 (en) * 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin

Also Published As

Publication number Publication date
PL371787A1 (en) 2005-06-27
EE200400110A (et) 2004-10-15
JP2006507216A (ja) 2006-03-02
CZ2004931A3 (cs) 2005-03-16
BG108870A (en) 2005-12-30
WO2003074033A1 (en) 2003-09-12
HRP20020124A2 (en) 2003-10-31
CA2476050A1 (en) 2003-09-12
SK3302004A3 (sk) 2005-04-01
AU2004205184A1 (en) 2005-03-03
US20050118266A1 (en) 2005-06-02
WO2003074033A8 (en) 2004-07-08
NO20043818L (no) 2004-09-30
IS7386A (is) 2004-08-05
RU2004127237A (ru) 2005-04-20
HUP0500097A3 (en) 2008-04-28
EP1474112A1 (en) 2004-11-10
RS70704A (en) 2006-10-27

Similar Documents

Publication Publication Date Title
HUP0500097A2 (hu) Nyújtott/szabályozott hatóanyag-leadású szilárd készítmény, mint kisebb dózisveszteséget mutató új hatóanyag-adagoló rendszer
WO2003103637A3 (en) MODIFIED RELEASE MULTIPLE UNIT DRUG DELIVERY SYSTEMS
WO2004108162A3 (en) Controlled release pharmaceutical composition
BR0014383A (pt) Composições de liberação controlada compreendendo nimesulida
WO2001082895A3 (en) Guaifenesin sustained release formulation and tablets
WO2005048996A3 (en) Modified release dosage forms of skeletal muscle relaxants
EA200101026A1 (ru) Предварительно желатинированный крахмал в композиции с контролируемым высвобождением
EA200000584A3 (ru) Твердые фармацевтические композиции с контролируемым высвобождением, получаемые тепловым формованием
MXPA04007427A (es) Formulaciones de azitromicina granuladas por via seca.
MY144297A (en) Pharmaceutical compositions
ATE235895T1 (de) Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis
BR0115965A (pt) Composições farmacêuticas para a liberação oral de agentes farmacologicamente ativos
DE69940557D1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
HUP0202781A2 (hu) Béta-karbolin szemcsés formája, ezt tartalmazó gyógyszerkészítmények, előállításaik és alkalmazásuk
RU2001110355A (ru) Независящие от влияния пищи фармацевтические дозированные препаративные формы пролонгированного действия, содержащие множество единиц, и способ их получения
SI2729130T1 (en) Combined formulations of darunavir
MA29770B1 (fr) Composition a liberation prolongee de l'actif, son procede de preparation et son utilisation
ATE375789T1 (de) Orales abgabesystem mit einem antibakteriellen und einem entzündungshemmenden mittel
DE60042972D1 (de) Trimetazidine enthaltendes Arzneimittel mit verzögerter Wirkstoffabgabe und Verfahren zur Herstellung
ATE290854T1 (de) Carbamazepinformulierung mit verzögerter freigabe
HUP0001780A2 (hu) Stabilizált tibolont tartalmazó készítmények és eljárás előállításukra
HUP0203338A2 (hu) Integrin receptor ligandumok
TW200509985A (en) Drug delivery system for sub-Tenon administration of fine particles
GEP20043377B (en) Pharmaceutical Complex
TR200301553A1 (tr) İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: PLIVA HRVATSKA D.O.O., HR

Free format text: FORMER OWNER(S): PLIVA-ISTRAZIVACKI INSTITUT D.O.O, HR; PLIVA ISTRAZIVANJE RAZVOJ D.O.O., HR; PLIVA ISTRAZIVANJE I RAZVOJ D.O.O., HR

GB9A Succession in title

Owner name: PLIVA HRVATSKA D.O.O., HR

Free format text: FORMER OWNER(S): PLIVA-ISTRAZIVACKI INSTITUT D.O.O, HR; PLIVA HRVATSKA D.O.O., HR; PLIVA ISTRAZIVANJE RAZVOJ D.O.O., HR; PLIVA ISTRAZIVANJE I RAZVOJ D.O.O., HR; PLIVA ISTRAZIVANJE I RAZVOJ D.O.O., HR

FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished